| Jeffrey W Rubin, MD | |
|
240 Heritage Walk, Suite 101, Woodstock, GA 30188-3875 | |
| (770) 516-7880 | |
| (770) 516-7870 |
| Full Name | Jeffrey W Rubin |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 40 Years |
| Location | 240 Heritage Walk, Woodstock, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720125131 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Northside Hospital Cherokee | Canton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physician Pain Care,p.c. | 1759457641 | 3 |
News Archive
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
The Affordable Care Act led to an increase in the number of cancer diagnoses - particularly those at early stages - in states where Medicaid was expanded, according to research from Indiana University.
A researcher at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) has secured a grant from the National Institutes of Health (NIH) to study how certain brain cells respond to chronic stress.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
Researchers have found that surgical instruments used for neurosurgery could get contaminated by the altered brain proteins that are seen in Alzheimer's disease. These instruments are capable of spreading the condition if not treated or decontaminated properly before reuse. The study results were published in the latest issue of the journal Nature.
› Verified 9 days ago
| Entity Name | Physician Pain Care,p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023273570 PECOS PAC ID: 1759457641 Enrollment ID: O20080828000463 |
News Archive
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
The Affordable Care Act led to an increase in the number of cancer diagnoses - particularly those at early stages - in states where Medicaid was expanded, according to research from Indiana University.
A researcher at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) has secured a grant from the National Institutes of Health (NIH) to study how certain brain cells respond to chronic stress.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
Researchers have found that surgical instruments used for neurosurgery could get contaminated by the altered brain proteins that are seen in Alzheimer's disease. These instruments are capable of spreading the condition if not treated or decontaminated properly before reuse. The study results were published in the latest issue of the journal Nature.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey W Rubin, MD 240 Heritage Walk, Suite 101, Woodstock, GA 30188-3875 Ph: (770) 516-7880 | Jeffrey W Rubin, MD 240 Heritage Walk, Suite 101, Woodstock, GA 30188-3875 Ph: (770) 516-7880 |
News Archive
Vemma Nutrition Company announces a partnership with Presbyterian Hospital in Charlotte, North Carolina to provide ultra-premium nutrition to underprivileged children. Through Vemma's NEXT Helping Now Project, for each month's supply sold, the company donates a month's supply of its children's nutritional supplement, Vemma NEXT, to a child in need. Vemma will make ongoing donations to the Presbyterian Hospital Community Care Cruiser so children in need throughout Charlotte can receive proper nutrition.
The Affordable Care Act led to an increase in the number of cancer diagnoses - particularly those at early stages - in states where Medicaid was expanded, according to research from Indiana University.
A researcher at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) has secured a grant from the National Institutes of Health (NIH) to study how certain brain cells respond to chronic stress.
Dyax Corp. announced today that results from EDEMA3, the Company's first Phase 3 trial evaluating KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema, were published in the August issue of The New England Journal of Medicine. KALBITOR, discovered and developed by Dyax, is available in the United States for the treatment of acute attacks of HAE in patients 16 years of age and older.
Researchers have found that surgical instruments used for neurosurgery could get contaminated by the altered brain proteins that are seen in Alzheimer's disease. These instruments are capable of spreading the condition if not treated or decontaminated properly before reuse. The study results were published in the latest issue of the journal Nature.
› Verified 9 days ago